Emerging drugs for small-cell lung cancer
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728210903206983
Reference103 articles.
1. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries
2. Cancer incidence and mortality in Europe, 2004
3. Gender and Histologic Type Variations in Smoking-Related Risk of Lung Cancer
4. Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. EGFR, NF-κB and noncoding RNAs in precision medicine;Progress in Molecular Biology and Translational Science;2022
2. Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes;Current Oncology;2021-01-08
3. Irreversible epidermal growth factor receptor inhibitor Z25h exhibits pronounced inhibition on non-small cell lung adenocarcinoma cell line Hcc827;Anti-Cancer Drugs;2020-10-19
4. Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer;Oncotarget;2017-04-05
5. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo;Molecular Cancer Therapeutics;2016-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3